- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01695031
Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens (PuffCityED)
Feasibility of an ED-initiated Online Asthma Management Program for Urban Teens (Puff City-ED)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participating emergency departments include Henry Ford Main, Henry Ford Fairlane, and Detroit Medical Center Children's hospital. Eligible teens will be 13-19 years of age. (Including 19 year olds in the the proposed sample means the data is comparable to age categories used by many federal agencies). Eligibility criteria include: a physician diagnosis of acute asthma at the ED visit and parent and teen written informed consent/assent. Eligibility criteria can be confirmed with the help of the ED nursing staff as some teens presenting with symptoms of acute asthma, may receive an asthma diagnosis for the first time in the ED. Using the investigator's data from the school-based trial of Puff City, investigators observed that 12.9% (20/155) of teens reporting an ED visit at baseline also reported no physician diagnosis. This is used as an approximation of the number of participants in the ED pilot that may be newly diagnosed. Teens previously enrolled in the school-based version of Puff City will not be eligible to participate in this pilot. Eligible teens are approached by a recruiter during down time in the ER (while waiting during receiving treatment or while waiting to be discharged). A study recruiter will provide the teen with an enrollment packet that includes an informational brochure (SD 1), a consent (SD 2), and an assent form (SD 3). The recruiter will go through these materials with the parents and teens and answer any questions they may have about the program. The recruited teens who enroll are randomized to either treatment or control. Both groups will be asked to complete an online baseline questionnaire before leaving the ED. An example of this questionnaire has been included with this application (SD 4). Once the baseline questionnaire is finished, teens will then be completing 4 online sessions of web-based asthma education on their own time on a computer with Internet access. Control group will receive commercial websites such as those sponsored by the American Lung Association; the American Academy of Allergy, Asthma and Immunology; the Asthma and Allergy Foundation, and others. Treatment group receives the 4 online, tailored educational sessions. Teens will be encouraged to complete the 4 sessions within 90 days, with a minimum of 7 days between sessions to allow for behavior change. To regulate dosage, control participants receive a "time expired" message after 30 minutes of browsing; this time limit is commensurate with the estimated time needed to complete a tailored session. Teens will also be asked to complete a 6-month follow-up survey (SD 5).Parents/Guardians of the enrolled teens will also be asked to complete a baseline questionnaire and a follow-up at 6 months (SD 6-7) in the form of a telephone interview with a trained interviewer.
In YR1 investigators will develop the recruitment protocol, hire and train recruiters, and establish a study database. Investigators will get on the agenda of CHM ED staff meetings to orient clinic staff to the intervention, obtain input/feedback, discuss logistics, address concerns, and answer questions about the project. Prior to recruitment Investigators will develop signage about the study (as appropriate) for the ED. Recruitment will start in month six of YR1, with at least two practice runs of the protocol. In YR2, investigators will continue recruitment and begin 6 month follow-up surveys. Recruitment will end in the fall of YR2 leaving 6-8 months for completion of follow-up, analysis and write-up. At the end of YR1 and again at the end of YR2, investigators will conduct short, qualitative interviews with ED and research staff to ensure identification of issues, barriers, and obstacles to conducting a trial of an ED-initiated version of Puff City.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Health System
-
Detroit, Michigan, United States, 48201
- Children's Hospital of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 13-19 years of age
- Physician diagnosis of acute asthma at the Emergency Department visit
- Parent written informed consent
- Teen written informed assent
Exclusion Criteria:
- Inability to provide informed consent/assent
- No physician diagnosis of asthma
- Other co-morbidities that make it impossible for individual to participate.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tailored asthma management program
Teens randomized to the experimental arm will receive 4 sessions of web-based, tailored asthma management
|
web-based, computer-tailored asthma management intervention delivered every week for 4 weeks
|
|
Active Comparator: Generic web-based education
Teens in the control group will receive generic, web-based asthma education.
|
Generic, web-based asthma education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emergency Department Visit
Time Frame: 12 months
|
Proportion of enrolled teens randomized to the treatment group who return to the ED with acute asthma compared to the proportion of enrolled teens randomized to the control group who return to the ED with acute asthma
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Asthma Control Test (ACT)
Time Frame: 12 months
|
Comparison of ACT scores at 12 months post-baseline by randomization group
|
12 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional Status
Time Frame: 12 months
|
Compare functional status (e.g., symptom-days, symptom-nights, days of restricted activity, school/work days missed, etc.) by randomization group at 12 months
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christine LM Joseph, PhD, MPH, Henry Ford Health System
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R34HL109296-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Asthma
-
Meyer Children's Hospital IRCCSRecruitingAsthma in Children | Asthma Acute | Asthma Crisis | Asthma ChildhoodItaly
-
Vanderbilt University Medical CenterWithdrawnAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
Sheffield Children's NHS Foundation TrustRecruitingDexamethasone | Acute AsthmaUnited Kingdom
-
Columbia UniversityChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingAcute Asthma | Pediatric Asthma | Non-invasive Positive Pressure Ventilation | BiPAPUnited States
-
Muhammad Aamir LatifCompletedAcute Exacerbation of AsthmaPakistan
-
Queen Mary University of LondonImperial College LondonRecruitingAsthma Acute | RespiratoryUnited Kingdom
-
Medentum InnovationsNational Institutes of Health (NIH); University of Arizona; El Rio Community...RecruitingAsthma Exacerbation | Pediatric Asthma | Acute Otitis Media (AOM) | Strep PharyngitisUnited States
-
University of KarachiEnrolling by invitationAsthma AcutePakistan
-
University of MonastirUnknownAcute AsthmaTunisia
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
Clinical Trials on Tailored asthma management program
-
Henry Ford Health SystemNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
The University of Texas Health Science Center at...Completed
-
Denver Health and Hospital AuthorityUniversity of Colorado, DenverCompleted
-
University of MichiganNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Nancy SchoenbergNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
China-Japan Friendship HospitalCompleted
-
University of Texas at AustinActive, not recruiting
-
University of GeorgiaYMCACompleted
-
Restech SrlRecruitingAsthmaItaly, Australia, France